Member Login
  1. Stocks
    2. /
  2. Bausch Health Companies Inc. (TSX: BHC)
    3. /

TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    These 2 Pharma Giants Are Trading at Steep Discounts

    | Jason Phillips

    Healthcare stocks are up 21% since the start of the year, yet Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) and one…

    Read more »

    Investing

    The Top 4 Stocks to Short as Rates Continue to Rise

    | Ryan Goldsman

    With higher interest expenses, companies such as Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may be the best short sell available.

    Read more »

    calm, no emotion
    Metals and Mining Stocks

    2 Turnaround Stocks Worth Considering

    | Demetris Afxentiou

    Cameco Corp. (TSX:CCO)(NYSE:CCJ) has dropped significantly over the past five years, but it is one of several stocks that still…

    Read more »

    The Motley Fool
    Investing

    4 Reasons Valeant Pharmaceuticals Intl Inc. Might Be a Good Investment Today

    | David Jagielski

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is down over 20% in the past month and could present a great buying opportunity.

    Read more »

    The Motley Fool
    Investing

    Better Turnaround Play: Bombardier, Inc. vs. Valeant Pharmaceuticals Intl Inc.

    | Joey Frenette

    Bombardier, Inc. (TSX:BBD.B) and Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are two popular contrarian picks. Here's which one investors should consider…

    Read more »

    The Motley Fool
    Investing

    3 Reasons You Should Be Wary of Valeant Pharmaceuticals Intl Inc.

    | Ambrose O'Callaghan

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a risky buy during a recovery period and with general headwinds building.

    Read more »

    The Motley Fool
    Investing

    Why an Investment in Valeant Pharmaceuticals Intl Inc. Needs to Be Long Term

    | Chris MacDonald

    Short-term traders should stay away from Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX), but long-term investors should take a look.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: Still a Risk or on the Way up?

    | Jacob Donnelly

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) could experience amazing growth, but with all that debt, it remains incredibly risky.

    Read more »

    The Motley Fool
    Investing

    Danger: 3 Types of Stocks to Avoid in a Rising Interest Rate Environment

    | Kay Ng

    Who controls interest rates? And why would it be dangerous to invest in stocks like Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX)…

    Read more »

    The Motley Fool
    Investing

    How Rising Rates May Bankrupt Valeant Pharmaceuticals Intl Inc.

    | Ryan Goldsman

    With higher rates leading to higher interest costs, shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) are on their way down.

    Read more »

    The Motley Fool
    Investing

    Long-Term Investors: Buy the Dip With Valeant Pharmaceuticals Intl Inc.

    | Chris MacDonald

    Where are shares of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) headed after extreme volatility of late?

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceutical Intl Inc. Is Back on the Growth Track: Time to Buy?

    | Joey Frenette

    Valeant Pharmaceutical Intl Inc. (TSX:VRX)(NYSE:VRX) suffered a massive 9.57% plunge following a huge +10% post-earnings rally. Should investors buy as…

    Read more »